PEAK1 and malignant colon neoplasm: For example, miR-19a inhibits colon cancer angiogenesis by targeting KRAS and VEGFA [28], and miR-181d reduces cell proliferation, migration, and invasion by triggering PEAK1, a downstream regulator of the EGFR/KRAS pathway [29].